CELEX: 62018TA0644
Language: en
Date: 2019-11-28 00:00:00
Title: Case T-644/18: Judgment of the General Court of 28 November 2019 — August Wolff v EUIPO — Faes Farma (DermoFaes Atopiderm) (EU trade mark — Opposition proceedings — Application for EU word mark DermoFaes Atopiderm — Earlier EU word mark Dermowas — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EU) 2017/1001)

27.1.2020   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 27/30
            
         
      Judgment of the General Court of 28 November 2019 — August Wolff v EUIPO — Faes Farma (DermoFaes Atopiderm)
      (Case T-644/18) (1)
      
      (EU trade mark - Opposition proceedings - Application for EU word mark DermoFaes Atopiderm - Earlier EU word mark Dermowas - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)
      (2020/C 27/37)
      Language of the case: English
      
         Parties
      
      
         Applicant: Dr. August Wolff GmbH & Co. KG Arzneimittel (Bielefeld, Germany) (represented by: A. Thünken, lawyer)
      
         Defendant: European Union Intellectual Property Office (represented by: J. Ivanauskas and H. O’Neill, acting as Agents)
      
         Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Faes Farma, SA (Lamiaco-Leioa, Spain) (represented by: A. Vela Ballesteros and S. Fernandez Malvar, lawyers)
      
         Re:
      
      Action brought against the decision of the Second Board of Appeal of EUIPO of 11 July 2018 (Case R 1305/2017-2) relating to opposition proceedings between Dr. August Wolff and Faes Farma.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  
                     Dismisses the action;
                  
               
            
                  2.
               
               
                  
                     Orders Dr. August Wolff GmbH & Co. KG Arzneimittel to bear its own costs and to pay the costs incurred by the European Union Intellectual Property Office (EUIPO) and by Faes Farma, SA, including those necessarily incurred by Faes Farma, SA, before the Board of Appeal of EUIPO.
                  
               
            
         (1)  OJ C 4, 7.1.2019.